This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, S. Articles by Diehl, A. M. Search for Related Content PubMed PubMed Citation Articles by Yang, S. Articles by Diehl, A. M.

Hepatic Hyperplasia in Noncirrhotic Fatty Livers

Is Obesity-related Hepatic Steatosis a Premalignant Condition?

Departments of Medicine [S. Y., H. Z. L., J. H., A. M. D.] and Radiology [V. P. C.], The Johns Hopkins University, Baltimore, Maryland 21205

It is not known whether obesity increases the risk for hepatocellular carcinoma (HCC) simply because it promotes cirrhosis, a general risk factor for HCC, or via some other mechanism that operates independently of cirrhosis. If the latter occurs, then hepatocyte hyperplasia, an early event during the neoplastic process, might begin before liver cirrhosis develops. Genetically obese, leptin-deficient ob/ob mice are models for nonalcoholic fatty liver disease (NAFLD), a type of liver disease that is strongly associated with obesity and type 2 diabetes. Similar to obese, diabetic patients, ob/ob mice have an increased incidence of HCC. However, unlike humans with NAFLD, they rarely, if ever, develop cirrhosis spontaneously. To determine whether the noncirrhotic livers of ob/ob mice with NAFLD exhibit hepatocyte hyperplasia, parameters of proliferation and apoptosis were compared in adult ob/ob mice and their healthy litter mates. Adult ob/ob mice have an increase in liver mass relative to body mass. This hepatomegaly cannot be explained solely by lipid accumulation and is accompanied by significant increases in hepatocyte proliferative activity (as evidenced by increased Erk activation, cell-cycle related gene expression, bromodeoxyuridine incorporation, and hepatic DNA content) with concomitant inhibition of hepatocyte apoptosis (as evidenced by decreased numbers of apoptotic hepatocytes, induction of several antiapoptotic mechanisms, and decreased activation of procaspase 3). Thus, liver hyperplasia is evident at the earliest stage of NAFLD in ob/ob mice, which supports the concept that obesity-related metabolic abnormalities, rather than cirrhosis, initiate the hepatic neoplastic process during obesity.

This article has been cited by other articles:

				A. E. Hill-Baskin, M. M. Markiewski, D. A. Buchner, H. Shao, D. DeSantis, G. Hsiao, S. Subramaniam, N. A. Berger, C. Croniger, J. D. Lambris, et al. Diet-induced hepatocellular carcinoma in genetically predisposed mice Hum. Mol. Genet., August 15, 2009; 18(16): 2975 - 2988. [Abstract] [Full Text] [PDF]

				M. N. VanSaun, I. K. Lee, M. K. Washington, L. Matrisian, and D. L. Gorden High Fat Diet Induced Hepatic Steatosis Establishes a Permissive Microenvironment for Colorectal Metastases and Promotes Primary Dysplasia in a Murine Model Am. J. Pathol., July 1, 2009; 175(1): 355 - 364. [Abstract] [Full Text] [PDF]

				M.-W. Yu, W.-L. Shih, C.-L. Lin, C.-J. Liu, J.-W. Jian, K.-S. Tsai, and C.-J. Chen Body-Mass Index and Progression of Hepatitis B: A Population-Based Cohort Study in Men J. Clin. Oncol., December 1, 2008; 26(34): 5576 - 5582. [Abstract] [Full Text] [PDF]

				J. Imai, H. Katagiri, T. Yamada, Y. Ishigaki, T. Suzuki, H. Kudo, K. Uno, Y. Hasegawa, J. Gao, K. Kaneko, et al. Regulation of Pancreatic {beta} Cell Mass by Neuronal Signals from the Liver Science, November 21, 2008; 322(5905): 1250 - 1254. [Abstract] [Full Text] [PDF]

				G. Marchesini, S. Moscatiello, S. Di Domizio, and G. Forlani Obesity-Associated Liver Disease J. Clin. Endocrinol. Metab., November 1, 2008; 93(11_Supplement_1): s74 - s80. [Abstract] [Full Text] [PDF]

				R. A. Jolly, R. Ciurlionis, D. Morfitt, M. Helgren, R. Patterson, R. G. Ulrich, and J. F. Waring Microvesicular Steatosis Induced by a Short Chain Fatty Acid: Effects on Mitochondrial Function and Correlation with Gene Expression Toxicol Pathol, February 1, 2004; 32(2_suppl): 19 - 25. [Abstract] [PDF]

				M L. Martinez-Chantar, E. R Garcia-Trevijano, M U. Latasa, I. Perez-Mato, M. M Sanchez del Pino, F. J Corrales, M. A Avila, and J. M Mato Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury Am. J. Clinical Nutrition, November 1, 2002; 76 (5): 1177S - 1182S. [Abstract] [Full Text] [PDF]

				M. Torbenson, S. Q. Yang, H. Z. Liu, J. Huang, W. Gage, and A. M. Diehl STAT-3 Overexpression and p21 Up-Regulation Accompany Impaired Regeneration of Fatty Livers Am. J. Pathol., July 1, 2002; 161(1): 155 - 161. [Abstract] [Full Text] [PDF]

				J. M. MATO, F. J. CORRALES, S. C. LU, and M. A. AVILA S-Adenosylmethionine: a control switch that regulates liver function FASEB J, January 1, 2002; 16(1): 15 - 26. [Abstract] [Full Text] [PDF]